Drugs / CD3/CD28 Activated T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00674427 | Jan 2008 → Jan 2012 | B-cell chronic lymphocytic leukemia, Hodgkins lymphoma, acute myeloid leukemia, chronic myeloid leukemia +2 | University of Pennsylvania | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD3/CD28 Activated T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00674427 ↗ |
| Modality | Cell therapy | “infusions of your bone marrow donor's immune cells (system which protects the body from disease); these immune cells are white blood cells called leukocytes or lymphocytes...” NCT00674427 ↗ |